CRUK Cancer Research UK, Abcam Partner to Develop Custom Antibodies for Cancer Research Abcam will develop custom protein-based reagents for AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials ArcherDx will develop sequencing-based circulating tumor DNA assays for use in AstraZeneca's recently launched Phase III MERMAID-1 trial of durvalumab (Imfinzi). Genetic Alterations in Breast Cancer Influence Tumor Ecosystems Researchers combined imaging mass spectrometry and genomic data to identify the cell types present in more than 480 breast cancer samples. New Early Cancer Detection Alliance to Trial Bevy of New Technologies and Tests Premium The number of technologies to be assessed is vast, and ranges from liquid biopsies and molecular imaging to immunohistochemistry and RNA-seq. Lung Cancer Studies From TRACERx Consortium Explore How Tumor Cells Evolve Researchers from the TRACERx consortium analyzed blood and tumor samples to tease out features of lung cancers that are more likely to recur. Apr 22, 2019 Liquid Biopsy Utility Reinforced in Early Results From UK TARGET Program Jan 23, 2019 Cancer Research UK Names Latest Grand Challenge Competition Winners Dec 14, 2018 In Brief This Week: Cancer Research UK, NeoGenomics, Luminex, and More Dec 11, 2018 In Race for Blood-Based Cancer Detection, More Teams Turn to Epigenetic, Fragment-Based Analysis Premium Nov 30, 2018 Liquid Biopsy Test to Guide Prostate Cancer Treatment Being Developed With £5M Award Premium Apr 18, 2018 AACR Business Roundup: Thermo Fisher, Mission Bio, Stand Up To Cancer, Cancer Research UK Nov 1, 2017 Natera Joins UK Longitudinal Breast Cancer Liquid Biopsy Study Aug 17, 2017 As Brexit Negotiations Unfold, UK Researchers and Institutions Remain Worried About Coming Changes Premium Apr 26, 2017 Lung Cancer Studies Yield Insight Into Tumor Evolution, Support Liquid Biopsy Potential Apr 3, 2017 Cancer Researchers Detail Efforts to 'Discover, Predict, Prevent, Treat' at Opening of AACR Meeting Mar 24, 2017 Cancer Research UK Invests £10M in Personalized Approach to Pancreatic Cancer Dec 1, 2016 CRUK's Personalized Breast Cancer Program Aims to Develop Clinical Sequencing Framework Premium Jan 26, 2016 Inivata Raises £31.5M in Series A Financing Round Nov 16, 2015 Exome, Targeted Sequencing of Biopsy, ctDNA Reveals Clonal Evolution of Breast Cancer Tumors Premium Oct 22, 2015 HSBC to Provide $25M to Support Francis Crick Institute Oct 1, 2015 Meta-Analysis Links Five New Variants to Brain Cancer Risk Sep 4, 2015 CRUK Reports Results of First Phase of Stratified Medicine Program as It Implements NGS Panel Premium Aug 21, 2015 CRUK Report Finds Cancer MDx Testing Lagging in UK Jun 26, 2015 CRUK Designates Three Centers as Research Hubs with £15M in Funding Apr 23, 2015 CRUK Manchester Institute Joins European Consortium Validating Blood-based Cancer Biomarkers Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.